ESC 365 - Permanent atrial fibrillation in HFREF and HFPEF: when and how to control rate?

EHRA Premium Access

Permanent atrial fibrillation in HFREF and HFPEF: when and how to control rate?

Session: New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Topic: Heart Failure and Left Ventricular Dysfunction

Speaker: Professor D. Kotecha (Birmingham, GB)

Event: EHRA 2018

Presentation

About the speaker

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

26 presentations

0 follower

3 more presentations in this session

The impact of atrial fibrillation in HFREF and HFPEF

Speaker: Professor A. Coats (Coventry, GB)

Is there a role for anti-arrhythmic drugs or catheter ablation?

Speaker: Professor F. Ruschitzka (Zurich, CH)

The mitral valve in patients with AF and HF - Do we need specific therapy?

Speaker: Professor R. Rosenhek (Vienna, AT)

Access the full session

New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Speakers: Professor D. Kotecha, Professor A. Coats, Professor F. Ruschitzka, Professor R. Rosenhek

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

Related content

Open Access

ICD Therapy in 2021: Saving lives while reducing shocks.

29 August 2021

This platform is supported by